What you should know about the new COVID-19 'Cicada' variant
medicalxpress - A new COVID-19 variant that some have dubbed the "Cicada" variant is quietly spreading across the globe, carrying an unusually high number of mutations that could help it slip past existing immunity, public health experts say. The strain of SARS-CoV-2, ca…
AI Summary: A newly identified SARS‑CoV‑2 lineage nicknamed "Cicada" is showing signs of increased spread, prompting CDC tracking and expert concern. Public health officials advise heightened surveillance, updated testing and genomic sequencing to determine transmissibility, immune escape and clinical impact, while researchers rush to characterize the variant’s risks and inform any needed response.
The new cholesterol guideline: What to know
medicalxpress - For the first time since 2018, a clinical guideline from the American College of Cardiology and the American Heart Association for screening and managing blood cholesterol levels has been updated and jointly published in the Journal of the American Colleg…
AI Summary: Updated cholesterol guidance proposes shifts in testing strategy and risk assessment that may change timing and targets for lipid screening. Clinicians and patients should expect revised thresholds and more personalized testing intervals as the guideline aims to better align prevention with individual cardiovascular risk—so yes, your testing schedule might get a makeover.
- Diet and Upstream Prevention — Community diets and upstream prevention fight heart disease (3)
- OTHER — Triglyceride drug failed to reduce arterial plaque (1)
- Screening and Risk Tools — Earlier screening, personalized risk: guidelines meet AI (3)
- Treatment Advances and Intensive LDL — Aggressive LDL and new drugs reshape prevention strategies (3)
- All Other Stories
Diet and Upstream Prevention — Community diets and upstream prevention fight heart disease
OTHER — Triglyceride drug failed to reduce arterial plaque
Screening and Risk Tools — Earlier screening, personalized risk: guidelines meet AI
Treatment Advances and Intensive LDL — Aggressive LDL and new drugs reshape prevention strategies
All Other Stories
Lost in space: Sperm struggles to navigate during weightless sex
medicalxpress - Scientists have used a tiny plastic "obstacle course" to test how much sperm would struggle to navigate during sex in the weightlessness of space.
AI Summary: New research shows sperm struggle to navigate and function in weightless conditions, suggesting microgravity could impair fertilization and complicate human reproduction beyond low-Earth orbit. Scientists warn these findings raise practical and biological questions for long-duration missions and potential colonization efforts, prompting calls for more reproductive biology studies in space.
Teens are driving the demand for online abortion pills via telehealth
medicalxpress - Teens in the U.S. are obtaining medication abortion pills through telehealth, and young people aged 18 to 24 are ordering medication abortion at much higher rates than older adults.
AI Summary: Telehealth provision of medication abortion has surged, reducing travel for many and prompting a noticeable uptick in online requests from teenagers. Reports show virtual care is reshaping access patterns and forcing healthcare systems and regulators to confront new realities around remote prescribing, confidentiality, and youth access to reproductive services.
When it comes to surgery, your doctor's leadership skills play a crucial role
medicalxpress - You're scheduled for surgery next week. You've likely looked up your surgeon's credentials, years of experience, and perhaps even patient reviews. You want reassurance that your surgeon has steady hands, deep expertise, and a thorough command of the proce…
AI Summary: New research links a surgeon’s leadership and team‑management skills to measurable differences in operating‑room performance and patient outcomes. Hospitals are being nudged to treat leadership training as clinical skill development rather than optional soft training — because apparently who’s in charge matters when someone’s insides are on the line.
Global study estimates over 250,000 meningitis deaths in 2023, with young children bearing a heavy toll
medicalxpress - In 2023, 259,000 people died from meningitis and 2.5 million people were infected with the disease globally, suggests a study published in The Lancet Neurology. Although death and infection rates have declined significantly since 1990, progress is insuffi…
AI Summary: A worldwide mortality analysis estimates more than 250,000 deaths from meningitis in 2023, with young children bearing the heaviest toll. The findings underline gaps in vaccination, surveillance and outbreak preparedness, and call for accelerated prevention efforts—particularly on campuses and in high‑risk populations—before the predictable heartbreak rolls around again.
Do you love sleeping with your pet? Science reveals there's a tricky trade‑off
medicalxpress - For some pet guardians, their pets are present in their lives from the moment they wake up to the moment they go to bed. This happens because cats, dogs and other companion animals are increasingly perceived as family members. I'm not talking about the di…
AI Summary: New research finds sleeping with pets can boost comfort and emotional wellbeing, but carries trade-offs: increased allergen exposure, more fragmented sleep and small infection risks. Experts advise weighing mental‑health gains against sleep quality and hygiene, and using pet‑free bedrooms when needed — because 'cute' is not a medical recommendation.
A gut microbe linked to the Mediterranean diet boosts muscle strength in mice
livescience - Researchers are exploring the prospect of using gut bacteria to boost muscle strength, after zeroing in on a microbe that does this in mice
AI Summary: Researchers identified a gut microbe associated with adherence to a Mediterranean-style diet that, when introduced to mice, improved muscle strength and mitochondrial-related signals. The findings suggest a microbiome-mediated pathway that could inform interventions for age-related muscle decline, though translation to humans remains unproven and will need careful clinical follow-up.
When everyday tasks become harder: Early clues to Alzheimer's disease
medicalxpress - For many older adults, life is full of routines. Making breakfast, paying bills, shopping, driving, managing appointments and keeping track of medications are tasks done almost automatically. For most, these routines run smoothly, but for some, small disr…
AI Summary: A study finds that small, progressive difficulties with routine daily tasks can be early indicators of Alzheimer’s disease, preceding obvious cognitive symptoms. Tracking functional changes may enable earlier detection, intervention and planning, shifting attention from memory tests alone to how people manage everyday life — yes, the missing teaspoons matter.
- Everyday task declines: early, subtle signals of pending Alzheimer’s (4)
- Labs and trials wrestle with hopeful but faltering Alzheimer's therapies (3)
- Sleep, blood and life-history markers expose rising dementia risk (4)
- All Other Stories
Everyday task declines: early, subtle signals of pending Alzheimer’s
Labs and trials wrestle with hopeful but faltering Alzheimer's therapies
Sleep, blood and life-history markers expose rising dementia risk
All Other Stories
Two States Sue Cord Blood Bank Over False Advertisements
Sarah Kliff and Azeen Ghorayshi / nytimes - The attorneys general of Texas and Arizona contend that Cord Blood Registry, which stores umbilical cord cells, profited from misleading new parents.
AI Summary: Two state attorneys general filed lawsuits alleging a cord‑blood bank made false or misleading claims about the future therapeutic value of stored units. The actions seek consumer remedies and penalties, challenging marketing that regulators say may have led families to pay for services based on overstated promises about potential medical uses.
UK government recommends maximum two hours of screen time for younger children: What the evidence says
medicalxpress - New UK government guidance recommends that screen time for children under two should be avoided, except for shared activities such as video calls. For children aged two to five, a maximum of an hour a day is suggested. The guidance also outlines that watc…
AI Summary: The UK government updated child‑health guidance recommending strict limits on young children’s screen time, citing evidence linking excessive use to delayed development and poorer sleep. The guidance urges parents and caregivers to prioritize interactive, non‑screen activities and age‑appropriate limits while acknowledging modern practicalities for families.
FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating Drugs
Frank Vinluan / medcitynews - Denali Therapeutics’ Avlayah received FDA approval for treating Hunter syndrome, a rare neurological disorder. The biologic medicine uses Denali’s proprietary drug delivery technology to cross the protective blood-brain barrier. The post FDA Approval for …
AI Summary: Regulators granted Denali accelerated approval for a brain‑penetrant therapy, recognizing promising early efficacy in a rare neurological indication and addressing unmet needs in CNS drug delivery. The pathway requires confirmatory trials to verify clinical benefit while enabling earlier patient access to a novel mechanism targeting central nervous system disease.
FDA approves 1st weekly basal insulin for Type 2 diabetes
Ella Jeffries / beckershospitalreview - The FDA has approved Novo Nordisk’s Awiqli (insulin icodec-abae), making it the first once-weekly basal insulin available in the U.S. for adults with Type 2 diabetes. Awiqli is indicated as an adjunct to diet and exercise and is intended to reduce injecti…
AI Summary: The FDA approved the first once‑weekly basal insulin for adults with Type 2 diabetes, providing an alternative to daily injections and aiming to improve adherence and glycemic control. Regulators based the decision on trials showing comparable efficacy and safety to daily basal insulins, potentially reshaping diabetes management.
FDA approves Rocket's gene therapy for ultra-rare immune disease
Lei Lei Wu / endpoints - A rare disease gene therapy from Rocket Pharmaceuticals has garnered FDA approval after an earlier rejection for manufacturing problems. The FDA on Thursday granted accelerated approval to Rocket Pharma’s gene therapy ...
AI Summary: The FDA granted approval to Rocket’s gene therapy for a pediatric immune disorder, marking the first regulatory ok for this specific treatment class in children and offering a one‑time corrective option for affected patients. The decision opens access while raising expectations for long‑term follow‑up and real‑world safety monitoring.
Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows
medicalxpress - New evidence from a Chinese cohort presented at the European Lung Cancer Congress (ELCC) 2026 shows that one-time low-dose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a non–risk based population, including indivi…
AI Summary: A large population‑based study found organized lung cancer screening reduced mortality even in people who never smoked, demonstrating the benefits of expanded CT screening criteria and systematic outreach. The results suggest screening programs can detect lethal disease earlier across broader risk groups, prompting reconsideration of current eligibility rules.
Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
Jess Mador, WABE / kffhealthnews - Thousands of employees are gone and last summer’s shooting resonates still at the Centers for Disease Control and Prevention headquarters and among the large public health community in Atlanta.
AI Summary: An internal crisis at the U.S. Centers for Disease Control has left staff demoralized after a year of firings, funding cuts and a workplace shooting. The acting chief vows to restore stability while the White House delays a permanent director nomination, prompting media scrutiny and debate over agency leadership and morale.
- Demoralized staff and leadership scramble at Atlanta's CDC (3)
- Inside the scramble for a permanent CDC director (3)
- Wider federal research cuts, RSV spread complicate CDC mission (3)
- All Other Stories
Demoralized staff and leadership scramble at Atlanta's CDC
Inside the scramble for a permanent CDC director
Wider federal research cuts, RSV spread complicate CDC mission
All Other Stories
12 Senate Democrats Unveil Plan to Cut Costs, Expand Coverage
Marissa Plescia / medcitynews - In a recent letter, Senate Democrats proposed lowering healthcare costs, expanding coverage and cracking down on insurance company practices.The post 12 Senate Democrats Unveil Plan to Cut Costs, Expand Coverage appeared first on MedCity News.
AI Summary: A group of Senate Democrats released a package targeting insurance costs and access, proposing steps to lower premiums, expand coverage pathways and increase oversight of insurers. The agenda signals a coordinated legislative push to tackle affordability and industry practices, setting the stage for heated negotiations with stakeholders who enjoy the current status quo.
- Medicaid enrollment threatened by work requirements and redeterminations (5)
- Other health policy, market and access stories (9)
- PBMs, insulin pricing face bipartisan and regulatory pressure (6)
- Senate Democrats push reforms to curb insurer power (4)
- All Other Stories
Medicaid enrollment threatened by work requirements and redeterminations
Other health policy, market and access stories
PBMs, insulin pricing face bipartisan and regulatory pressure
Senate Democrats push reforms to curb insurer power
All Other Stories
Pfizer Lyme vaccine candidate heads to FDA
Ella Jeffries / beckershospitalreview - Pfizer and Valneva’s investigational Lyme disease vaccine candidate, PF-07307405 (LB6V), demonstrated more than 70% efficacy in preventing Lyme disease among individuals age 5 and older, according to topline phase 3 trial results. The prespecified analysi…
AI Summary: Pfizer is advancing a Lyme disease vaccine toward FDA submission despite a messy late‑stage picture: efficacy signals above 70% were reported while a pivotal trial missed its primary endpoint and struggled with low case numbers. Regulators must weigh public health need against statistical nuance as the company pushes for licensure.
Innovative research captures emotional and social realities of denture wearers
medicalxpress - Researchers at the University of Sheffield have developed a new patient-focused tool designed to better understand the lived experience of people wearing removable partial dentures. In their study published in the journal Gerodontology, the researchers in…
AI Summary: An international ACT for Children delegation visited Yerevan to support Armenia’s pediatric oncology services through training, resource sharing, and collaborative program development. The visit focused on strengthening local clinical capacity, improving access to treatments, and forging partnerships to advance childhood cancer care—practical help rather than platitudes, with an eye on sustainable improvements.
- Global systems and communication: policy, partnerships, and cultural context (3)
- OTHER: Unrelated health research (denture study) (1)
- Survivorship care: long-term needs, nursing, and AI solutions (3)
- Yerevan visit: ACT for Children strengthens local pediatric oncology care (3)
- All Other Stories
Global systems and communication: policy, partnerships, and cultural context
OTHER: Unrelated health research (denture study)
Survivorship care: long-term needs, nursing, and AI solutions
Yerevan visit: ACT for Children strengthens local pediatric oncology care
All Other Stories
Scream your way to happiness? Maybe not, but scream clubs promise some relief
medicalxpress - With a gut-wrenching wail that rippled from her body, Amber Walcker joined about a dozen screaming people in West Seattle who let their frustrations float away over the Puget Sound.
AI Summary: Scream clubs tout catharsis and quick emotional relief, but evidence for lasting mental‑health benefits is sparse. Research suggests short‑lived mood boosts largely driven by social bonding and novelty rather than durable therapeutic change. In short: yelling at strangers might feel good for a night, but don’t expect it to replace therapy.